"We will continue to watch over the border and prevent anyone from crossing it and entering Israel except in a few isolated and exceptional circumstances - each of which will be weighed on its own merit, " Mr Netanyahu said.
Novartis had argued that it needed a patent to protect its investment in the cancer drug Glivec, while activists said the drug did not merit intellectual property protection in India because it was not a new medicine.
"We conclude that all of Simpson's arguments on appeal are without merit and we therefore affirm the judgment of conviction, " Nevada's high court said in its ruling.